Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell activation via antigen presentation is a fundamental process in adaptive immunity, where T cells are primed to respond to pathogens or abnormal cells. This process requires the interaction between T cell receptors (TCRs) and antigens presented by major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells (APCs), along with additional costimulatory signals. Key components include APCs (dendritic cells, macrophages, B cells), MHC Class I and II molecules, TCR recognition, and costimulatory signals (CD28/B7, LFA-1/ICAM-1, CD40/CD40L). Activation involves antigen recognition (signal one), costimulation (signal two), immunological synapse formation, and intracellular signaling cascades. Outcomes include clonal expansion, cytokine secretion, and target cell killing. Failure in proper signaling can result in immune deficiency or autoimmunity; manipulation forms a basis for immunotherapies.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T Cell Activation via Antigen Presentation.